This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Otsuka Holdings Co., Ltd.
Drug Names(s): OPC-41061, Samska, Jinarc
Description: Tolvaptan is an orally active, small molecule antagonist that blocks arginine vasopressin from binding to V2 receptors of the distal nephron. This induces the excretion of electrolyte-free water without changing the total level of electrolyte excretion.
Additional information available to subscribers only: